Dave Moore, senior vice president of U.S. operations at Novo Nordisk, says his company wants to “meet patients where they are.” ...

Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a reduced price on several telehealth platforms.

Novo Nordisk is partnering with online telehealth companies to sell a direct-to-consumer ... of its weight-loss GLP-1 medication Wegovy at a reduced cost of $499. All doses will be delivered ...

The companies will sell the drug at a ... for purchase through the telehealth companies Ro, Hims and LifeMD for a reduced price of $499 per month. The Wegovy medication will come in the same ...

Novo Nordisk said that it will begin offering its popular weight loss drug Wegovy through telehealth companies Hims & Hers, Ro and LifeMD to expand patient access, now that the medication is no longer ...

can receive Wegovy (0.25mg, 0.5mg, 1mg, 1.7mg, and 2.4mg) at a reduced cost of $499 per month. Commenting on the integration, ...

Novo Nordisk is expanding access to its GLP-1 drug Wegovy via telehealth, partnering with Hims and Hers, Ro, and LifeMD.

It also recently aligned itself with telehealth companies Hims & Hers, Ro, and LifeMD to sell Wegovy at a discount for cash customers. "As the leader in obesity care for more than a decade ...

Hims & Hers Health Inc. soared after Novo Nordisk A/S said it would sell its popular weight-loss drug Wegovy for a steeply reduced price on several telehealth platforms. The strategy comes as ...